Cardiovascular Disease and Stroke in Immune TTP–Challenges and Opportunities

Advances in the management of immune thrombotic thrombocytopenic purpura (iTTP) have dramatically improved outcomes of acute TTP episodes, and TTP is now treated as a chronic, relapsing disorder. It is now recognized that iTTP survivors are at high risk for vascular disease, with stroke and myocardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukumar, Senthil, Mazepa, Marshall A., Chaturvedi, Shruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531888/
https://www.ncbi.nlm.nih.gov/pubmed/37762903
http://dx.doi.org/10.3390/jcm12185961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531888/
https://www.ncbi.nlm.nih.gov/pubmed/37762903
http://dx.doi.org/10.3390/jcm12185961

Ejemplares similares